Advert: 728x90carrotpharmadec09
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: GoIndPfizerJan2010_300x250
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home > Industry News > UK News
Hline
Advert: 160x600px-Gold-Wide-Skyscraper
LATEST UK NEWS Rss Feed
Brown steps up election tactics with cancer care pledges
Prime Minister Gordon Brown has revealed his latest move as the pre-election battle hots up with a promise of free one-to-one home care for cancer patients by specialist nurses.

UK green light for Herceptin in gastric cancer
Patients with gastric cancer in the UK have been given access to a new treatment option following the extended approval of Swiss drugmaker Roche’s biologic Herceptin.

AstraZeneca hooks up with CRT in major cancer deal
AstraZeneca and Cancer Research Technology are putting their heads together under a major three-year pact designed to generate “a stream” of new therapies targeting cancer metabolism.

Scottish cost regulators OKs Alimta and Stelara for NHS use
The Scottish Medicines Consortium has approved the use of Eli Lilly’s Alimta for lung cancer and Janssen-Cilag’s Stelara for psoriasis on the National Health Service.

FDA OKs wider use of AstraZeneca’s Crestor
Shares in AstraZeneca are on the rise this morning after US regulators gave the go-ahead for wider use of its blockbuster Crestor and allow it to be marketed as a preventative treatment for people who have normal or slightly elevated cholesterol levels

Millions of prescribed drugs passed on to friends and family
Lloydspharmacy has issued a warning over the dangers of taking medicines prescribed for someone else after research revealed that millions of doses are passed on to friends and family every year.

More Headlines
Arrow BREAKING NEWS: GSK coy on job loss numbers as new restructuring hits R&D
Arrow APPG meeting puts medicines compliance in spotlight again
Arrow Pfizer rolls out new generics portfolio in the UK
Arrow Dementia warning as costs spiral to £23 billion a year
Arrow Self-care schemes could save NHS millions, report claims
Arrow The Lancet retracts Wakefield’s flawed MMR paper
Arrow Legal fight fails to sway NICE osteoporosis guidance
Arrow 300 branded drug prices slashed in Ireland
Arrow MHRA advice highlights generic substitution dangers, says Norgine
Arrow Uncertain future for AZ’s Iressa as NICE asks for more data
Arrow Syntropharma signs up Ranbaxy in lucrative US deal
Arrow GSK silent on job cut rumours, new Tykerb OK

Older >
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
LATEST JOBS
Arrow   UK Partnership Development Manager
Arrow   Account Manager
Arrow   Senior Account Manager/Account Manager Flexible Remote Home Working/Office
Arrow   Key Account Manager
Arrow   Business Manager - Oncology
Arrow   Safety Physicians – all levels
Arrow   European Head of Business Development
Arrow   GP/Hospital Representative
Arrow   Field Trainer
Arrow   Client Service Executive
 
line
flickrtwitteryoutube